Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
ADHERE data show VYVGART® Hytrulo has potential to be first advancement for CIDP patients in 30 years
Real-world data demonstrate gMG patients able to significantly reduce steroid use over first six months of initiating VYVGART® treatment
Posted In: ARGX